Werewolf Therapeutics, Inc. (HOWL)
USD 1.48
(-9.76%)
USD 1.48
(-9.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -32.61 Million | -40.59 Million | -42.87 Million | -18.62 Million | -9.54 Million |
| Net Income | -37.36 Million | -53.81 Million | -49.98 Million | -15.04 Million | -10.24 Million |
| Depreciation & Amortization | 1.76 Million | 1.1 Million | 216 Thousand | 150 Thousand | 25 Thousand |
| Deferred income taxes | 4.33 Million | - | - | -7.3 Million | -117 Thousand |
| Stock-based compensation | 8 Million | 7.4 Million | 4.09 Million | 632 Thousand | 559 Thousand |
| Change in working capital | -5.89 Million | 2.53 Million | 2.27 Million | 2.3 Million | -711 Thousand |
| Other non-cash items | -3.45 Million | 2.17 Million | 519 Thousand | 627 Thousand | 950 Thousand |
| Investing Cash Flow | -769 Thousand | -3.61 Million | -498 Thousand | -560 Thousand | -266 Thousand |
| Investments in PPE | -769 Thousand | -3.61 Million | -498 Thousand | -560 Thousand | -266 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 58.42 Million | 15.9 Million | 109.42 Million | 93.85 Million | 21.9 Million |
| Debt repayment | -40 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 58.42 Million | 16.19 Million | 111.6 Million | 94.01 Million | 2000.00 |
| Other Financing Activities | 40.1 Million | -285 Thousand | -2.17 Million | -155 Thousand | 21.9 Million |
| Accounts receivables | 5.57 Million | -6.92 Million | - | - | - |
| Accounts payables | -4.33 Million | -883 Thousand | 1 Million | 388 Thousand | 116 Thousand |
| Inventory | - | 6.92 Million | - | - | - |
| Other working capital | -7.13 Million | 3.42 Million | 1.27 Million | 1.92 Million | -827 Thousand |
| Cash at beginning of period | 129.31 Million | 158.83 Million | 92.77 Million | 18.1 Million | 6 Million |
| Cash at end of period | 134.34 Million | 130.52 Million | 158.83 Million | 92.77 Million | 18.1 Million |
| Capital Expenditure | -769 Thousand | -3.61 Million | -498 Thousand | -560 Thousand | -266 Thousand |
| Effect of forex changes on cash | -20.02 Million | - | - | - | - |
| Net cash flow / Change in cash | 5.02 Million | -28.3 Million | 66.05 Million | 74.67 Million | 12.1 Million |
| Free Cash Flow | -33.38 Million | -44.2 Million | -43.37 Million | -19.18 Million | -9.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.24 Million | -16.19 Million | -12 Million | -37.36 Million | -8.28 Million | -5.09 Million |
| Depreciation & Amortization | 454 Thousand | 464 Thousand | 460 Thousand | 1.76 Million | 445 Thousand | 434 Thousand |
| Deferred income taxes | - | - | -2.8 Million | 4.33 Million | -3.11 Million | - |
| Stock-based compensation | 2.6 Million | 2.3 Million | 1.87 Million | 8 Million | 2.09 Million | 1.93 Million |
| Change in working capital | 589 Thousand | -2.34 Million | 4.63 Million | -5.89 Million | -2.09 Million | -8.59 Million |
| Other non-cash items | 223 Thousand | 5.59 Million | 3.26 Million | -3.45 Million | 3.73 Million | 409 Thousand |
| Investing Cash Flow | -17 Thousand | -111 Thousand | -198 Thousand | -769 Thousand | -221 Thousand | -182 Thousand |
| Investments in PPE | -17 Thousand | -111 Thousand | -198 Thousand | -769 Thousand | -221 Thousand | -182 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -9.72 Million | 20.25 Million | 9.07 Million | 58.42 Million | 41 Thousand | 692 Thousand |
| Debt repayment | -10.67 Million | - | -40 Million | -40 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 953 Thousand | 20.25 Million | 9.07 Million | 58.42 Million | 41 Thousand | 675 Thousand |
| Other Financing Activities | -9.72 Million | 12 Thousand | 9.07 Million | 40.1 Million | -20 Thousand | 17 Thousand |
| Accounts receivables | 230 Thousand | 575 Thousand | 4.56 Million | 5.57 Million | 1.01 Million | -672 Thousand |
| Accounts payables | 2.48 Million | -2.46 Million | -4.57 Million | -4.33 Million | -104 Thousand | -616 Thousand |
| Inventory | - | - | 5.33 Million | - | - | 672 Thousand |
| Other working capital | -2.12 Million | -447 Thousand | -693 Thousand | -7.13 Million | -3 Million | -7.98 Million |
| Cash at beginning of period | 139.18 Million | 134.34 Million | 130.26 Million | 129.31 Million | 137.45 Million | 169.08 Million |
| Cash at end of period | 135.3 Million | 139.18 Million | 134.34 Million | 134.34 Million | 130.26 Million | 158.67 Million |
| Capital Expenditure | -17 Thousand | -111 Thousand | -198 Thousand | -769 Thousand | -221 Thousand | -182 Thousand |
| Effect of forex changes on cash | - | - | -215 Thousand | -20.02 Million | 204 Thousand | - |
| Net cash flow / Change in cash | -3.88 Million | 4.84 Million | 4.07 Million | 5.02 Million | -7.18 Million | -10.41 Million |
| Free Cash Flow | -14.19 Million | -15.4 Million | -4.78 Million | -33.38 Million | -7.42 Million | -11.1 Million |
NVVEW
THO
0255
BESI
A3D
ADZ